HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Deals Russian Federation Business Strategies

Stada Grows In Russia And CIS With Takeda Brands

  • News

Executive Summary

Stada will pay $660m for a basket of 20 brands from Takeda to expand its consumer health portfolio in Russia and a number of strategically important CIS markets.

You may also be interested in...



Stada UK Head On COVID-19 Impact, Local Growth Strategy And OTC Brand Innovation

Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.

Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits

Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level. 

Hypera Strikes Takeda Deal To Dominate Brazil's OTC Market

Brazil's Hypera is paying Takeda $0.8bn for a portfolio of brands which will make it the "undisputed leader" in the South American country's OTC market. 

Table

View full table

Related Content

Generics Bulletin
HBW Insight
HBW Insight
HBW Insight
HBW Insight
HBW Insight

Topics

Related Companies

Tags:
Deals Russian Federation Business Strategies
UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By